IMMUNOCLIN CORP COM USD0.001 (IMCL: OTC)
$0.1501 -0.004 | -2.59%
04/13/17 - 02:24 PM ET
TheStreet Ratings Grade for IMCL
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions.
Analyst Ratings data is not available for IMCL.
Portfolios with IMCL
- Portfolio NameUser Type
- ContributorBarron's Interview Carl Icahn
- UserRAPTOR SPRTD-0710080827
- UserRAPTOR 230 SPRTD
- UserFast Money's Biotech Trades...
- UserFast Money's Whale Trades
- UserSoftWhere Portfolio 1
- UserFast Money's ASCO Biotech T...
- UserASCO is coming...Papers rel...
- Useramarmaharaj Portfolio 1
Latest IMCL Headlines from TheStreet
- Criminal Advice - Never Steal Anything Small: Gary Weiss 06.07.10 | 07:06 am
- Report: Eli Lilly Looks To Make More Deals 03.31.09 | 10:03 am
- Amylin Nominates 2 New Directors Amid Proxy Fight 03.30.09 | 12:03 pm
- Report: Swiss Drugmaker Nycomed Shopping Itself 03.23.09 | 04:03 pm
- Pfizer: Now What 01.27.09 | 02:01 pm
- GenVec Stock Hit by Pancreas Study's Details 11.19.08 | 01:11 pm
- They Just Don't Get Lilly! 10.24.08 | 09:10 am
- Cramer: Adding Bristol-Myers 10.18.08 | 02:10 pm
- Action Alerts Plus Update: Adding Bristol-Myers 10.16.08 | 11:10 am
- Health Winners & Losers: Eli Lilly 10.14.08 | 04:10 pm
Press Releases for IMCL
- Subsidiary Of ImmunoClin Corporation (IMCL) Receives Controlled Drug License In The United Kingdom - PR Newswire 04.02.15 | 12:04 pm
- ImmunoClin Corporation (IMCL) Relocates European Headquarters And Laboratories To London, UK - PR Newswire 03.10.15 | 10:03 am
- Cannabis Science Announces Corporate Changes, Appointing Raymond Dabney As President And CEO And Dr. Dorothy Bray As Scientific Advisory Board Chair And Clinical Development Consultant - PR Newswire 11.06.14 | 06:11 am
- Cannabis Science, Inc. (CBIS) Signs Drug Development And Laboratory Services Agreement With ImmunoClin Corporation (IMCL); Collaboration To Advance Clinical Studies And Formulations Of The Company's Proprietary Cannabinoid Based Products - PR Newswire 09.29.14 | 01:09 pm
- ImmunoClin Corporation (IMCL) Announces The Appointment Of Infectious Disease Expert, Dr. Heinz Ellerbrok, To The Company's Scientific Advisory Board - PR Newswire 08.05.14 | 11:08 am
- ImmunoClin Corporation (IMCL) Relocates Corporate Headquarters To Washington, DC - PR Newswire 07.29.14 | 09:07 am
- ImmunoClin Corporation (IMCL) Recruits Prof. Jean Mariani To The Company's Scientific Advisory Board - PR Newswire 06.05.14 | 10:06 am
- ImmunoClin Corporation (IMCL) Appoints Prof. Antony Bayer To The Company's Scientific Advisory Board - PR Newswire 05.27.14 | 07:05 am
- ImmunoClin Corporation (IMCL) Announces The Appointment Of Computing Systems Specialist And Entrepreneur, Mr. Railton Frith, To The Company's Scientific Advisory Board - PR Newswire 05.22.14 | 07:05 am
- ImmunoClin Corporation (IMCL) Proudly Announces The Appointment Of Molecular Biologist And Virologist, Dr. Marco Kaiser To The Company's Scientific Advisory Board - PR Newswire 04.30.14 | 08:04 am
Partner Headlines for IMCL
- Waksal brothers reunite in ImClone 2.0 - CNBC 09.25.14 | 01:09 pm